Welcome to our dedicated page for Stratasys (ISRAEL) news (Ticker: SSYS), a resource for investors and traders seeking the latest updates and insights on Stratasys (ISRAEL) stock.
Stratasys Ltd. reports developments in polymer 3D printing and additive manufacturing for industrial, dental, medical and product-design applications. Company updates commonly cover connected 3D printers, polymer materials, GrabCAD software, parts on demand through Stratasys Direct, and platform families that include FDM, PolyJet, P3 DLP and SLA technologies.
Recurring news also includes quarterly and annual financial results, conference-call materials, product and material launches, application expansion in aerospace, automotive, consumer products, healthcare and defense, and regulatory milestones such as European certification for TrueDent dental resins. The company also announces Form 20-F availability and other public-company reporting matters as a Nasdaq-listed foreign issuer.
Stratasys Ltd. (SSYS) reported a Q4 2021 revenue of $167 million, marking a 17.3% increase year-over-year. However, the company experienced a GAAP net loss of $4.8 million or $0.07 per diluted share. Non-GAAP net income stood at $0.5 million, reflecting a decline from previous figures. The company generated $4.4 million in cash from operations, ending the year with $502.2 million in cash and no debt. Looking ahead, Stratasys expects 2022 revenue between $680 million and $695 million with growth anticipated in the second half.
Stratasys (NASDAQ: SSYS) has collaborated with Radford to produce over 500 3D-printed parts for the Lotus Type 62-2 supercar, featured in the Discovery+ show Radford Returns. This partnership showcases the integration of advanced 3D printing technologies, such as FDM and PolyJet, in automotive manufacturing. The project exemplifies the shift towards customized manufacturing, allowing for unique vehicle designs with efficiency. The use of various Stratasys printers enabled Radford to achieve design freedom and meet the expectations of luxury vehicle aesthetics.
Summary not available.
Stratasys announced a sponsorship for the University of Minnesota Visible Heart Laboratories, donating advanced 3D printing technology including Stratasys J750 Digital Anatomy printers. These tools will enhance medical research, education, and device development by producing realistic anatomic models. The initiative aims to train medical students and improve patient outcomes through detailed anatomical education and advanced medical device testing.
Stratasys emphasizes the importance of community support and aims to foster innovation in healthcare.
Stratasys Ltd (NASDAQ: SSYS) will announce its financial results for Q4 and full year 2021 on February 23, 2022 at 8:30 a.m. ET. A conference call will follow to discuss these results. Investors can access the call via a live webcast on the company’s investor relations website or by telephone at 877-407-0619 (U.S.) and +1-412-902-1012 (international). Stratasys is at the forefront of additive manufacturing, providing innovative 3D printing solutions across various industries including aerospace and healthcare, enhancing design and manufacturing agility.
MakerBot, a Stratasys company (NASDAQ: SSYS), is expanding its 3D printing materials with three new LUVOCOM® 3F products from LEHVOSS Group. This addition brings the total number of METHOD® materials to 30, enhancing options for engineering applications. The new materials feature high strength and heat resistance, suitable for prototyping and end-use parts. Notably, they provide enhanced performance characteristics, such as reduced warpage and excellent surface finish, improving the overall 3D printing experience.
Stratasys (NASDAQ: SSYS) will participate in the 24th Annual Needham Growth Conference from January 10–14, 2022. A fireside chat featuring CEO Dr. Yoav Zeif and incoming CFO Eitan Zamir will take place on January 13, 2022, at 12:30 p.m. ET. The event will be broadcast live and archived for 180 days, accessible at this link. Stratasys is recognized for its innovative 3D printing solutions across various industries, enhancing product design and manufacturing efficiency.
Stratasys Ltd. (NASDAQ: SSYS) announced the promotion of Eitan Zamir to chief financial officer, effective February 2022. Zamir, previously the vice president of finance, succeeds Lilach Payorski, who served nine years in the role. Zamir has proven financial expertise and has been integral in financial operations, reporting, and capital raising since joining Stratasys in 2019. CEO Dr. Yoav Zeif praised Zamir's leadership qualities, underscoring his alignment with the company’s growth strategy.
Stratasys has unveiled the Origin One Dental 3D printer, enhancing its offerings in the dental sector. This printer is designed for high accuracy and efficiency, capitalizing on the growing demand in the dental market, which is projected to reach $6.5 billion by 2025. Built on proprietary P3™ technology, it offers an open material infrastructure for diverse applications. This launch aligns with Stratasys' acquisition of Origin and complements their existing J5 DentaJet printer, together aiming to address the needs of modern dental labs.
Stratasys has launched the Digital Anatomy Creator software to enhance its Digital Anatomy 3D Printers, allowing healthcare providers to create patient-specific anatomic models more effectively. This software offers advanced customization options, enabling users to replicate human tissues accurately for diagnostic purposes and surgical preparation. Additionally, Stratasys collaborates with Synopsys and Materialise to integrate FDA 510(k)-cleared workflows in medical modeling, which facilitates point-of-care 3D printing. Healthcare providers can use this technology to improve surgical outcomes and reduce operational costs.